LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS, ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASELIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS, ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

Lipoprotein-associated Phospholipase A2 (Lp-PLA2), has inflammatory and atherogenic effect on vasculature. Hence, we examine the impact of high Lp-PLA2 levels on endothelial function and arterial stiffness of patients with coronary artery disease (CAD). We enrolled 374 patients with stable CAD.